Jiang Zhu

Title: Innovations in Hemostasis: The Contributions of Jiang Zhu

Introduction

Jiang Zhu is a notable inventor based in Nantong, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of hemostatic agents. His innovative work addresses critical medical challenges, particularly in managing hemorrhages associated with jaw central hemangiomas.

Latest Patents

Jiang Zhu holds a patent for a hemostatic agent specifically designed for jaw central hemangioma hemorrhage. The patent describes a preparation method that involves the reaction of chitosan powder and organic weak acid in organic alcohol to create a chitosan weak acid salt. This agent is then mixed with carboxymethyl chitosan to produce a hemostatic solution. The resulting hemostatic agent exhibits excellent fluidity and plasticity, allowing it to effectively reach the site of hemorrhage without causing tissue damage. Additionally, it has antibacterial properties that help prevent cross-infection, making it a safe and effective option for treating significant hemorrhages.

Career Highlights

Jiang Zhu is affiliated with Nantong University, where he continues to engage in research and development in the biomedical field. His work has garnered attention for its practical applications in clinical settings, particularly in surgical procedures involving jaw central hemangiomas.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Jiang Zhu's innovative contributions to the field of hemostatic agents demonstrate the potential for advancements in medical treatments. His patent not only addresses a specific medical need but also showcases the importance of research in improving patient outcomes.